Overview
Maki Kobayashi practices in Tokyo, Japan. Kobayashi is highly rated in 1 condition, according to our data. Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Chronic Obstructive Pulmonary Disease (COPD), and Cerebellar Degeneration.
Their clinical research consists of co-authoring 35 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerKobayashi isAdvanced. Learn about Lung Cancer.
- Experienced
- Breast CancerKobayashi isExperienced. Learn about Breast Cancer.
- Cerebellar DegenerationKobayashi isExperienced. Learn about Cerebellar Degeneration.
- Chronic Obstructive Pulmonary Disease (COPD)
- EGFR Positive Lung CancerKobayashi isExperienced. Learn about EGFR Positive Lung Cancer.
- Inflammatory Myofibroblastic TumorKobayashi isExperienced. Learn about Inflammatory Myofibroblastic Tumor.
- Lung AdenocarcinomaKobayashi isExperienced. Learn about Lung Adenocarcinoma.